InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · IEX Real-Time Price · USD
0.265
-0.005 (-1.67%)
Jul 19, 2024, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Statistics

Total Valuation

INM has a market cap or net worth of $2.36 million. The enterprise value is -$4.94 million.

Market Cap 2.36M
Enterprise Value -4.94M

Important Dates

The next estimated earnings date is Wednesday, September 11, 2024, before market open.

Earnings Date Sep 11, 2024
Ex-Dividend Date n/a

Share Statistics

INM has 8.92 million shares outstanding. The number of shares has increased by 188.83% in one year.

Shares Outstanding 8.92M
Shares Change (YoY) +188.83%
Shares Change (QoQ) +20.56%
Owned by Insiders (%) 0.58%
Owned by Institutions (%) 4.85%
Float 8.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.42
Forward PS n/a
PB Ratio 0.21
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.58, with a Debt / Equity ratio of 0.03.

Current Ratio 6.58
Quick Ratio 5.14
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -53.40% and return on invested capital (ROIC) is -58.00%.

Return on Equity (ROE) -53.40%
Return on Assets (ROA) -45.30%
Return on Capital (ROIC) -58.00%
Revenue Per Employee $432,748
Profits Per Employee -$467,405
Employee Count 13
Asset Turnover 0.42
Inventory Turnover 2.71

Taxes

In the past 12 months, INM has paid $1,800 in taxes.

Income Tax 1,800
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -71.84% in the last 52 weeks. The beta is 0.60, so INM's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change -71.84%
50-Day Moving Average 0.27
200-Day Moving Average 0.37
Relative Strength Index (RSI) 50.10
Average Volume (20 Days) 673,532

Short Selling Information

The latest short interest is 84,651, so 0.95% of the outstanding shares have been sold short.

Short Interest 84,651
Short Previous Month 150,003
Short % of Shares Out 0.95%
Short % of Float 1.02%
Short Ratio (days to cover) 0.07

Income Statement

In the last 12 months, INM had revenue of $5.63 million and -$6.08 million in losses. Loss per share was -$0.85.

Revenue 5.63M
Gross Profit 2.21M
Operating Income -6.64M
Pretax Income -6.07M
Net Income -6.08M
EBITDA -5.47M
EBIT -6.07M
Loss Per Share -$0.85
Full Income Statement

Balance Sheet

The company has $7.64 million in cash and $345,545 in debt, giving a net cash position of $7.30 million or $0.82 per share.

Cash & Cash Equivalents 7.64M
Total Debt 345,545
Net Cash 7.30M
Net Cash Per Share $0.82
Equity (Book Value) 11.10M
Book Value Per Share 1.25
Working Capital 8.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.61 million and capital expenditures -$42,899, giving a free cash flow of -$6.66 million.

Operating Cash Flow -6.61M
Capital Expenditures -42,899
Free Cash Flow -6.66M
FCF Per Share -$0.69
Full Cash Flow Statement

Margins

Gross margin is 39.20%, with operating and profit margins of -118.06% and -108.01%.

Gross Margin 39.20%
Operating Margin -118.06%
Pretax Margin -107.98%
Profit Margin -108.01%
EBITDA Margin -97.25%
EBIT Margin -107.98%
FCF Margin -118.34%

Dividends & Yields

INM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -188.83%
Shareholder Yield -188.83%
Earnings Yield -257.38%
FCF Yield -282.00%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on September 7, 2022. It was a reverse split with a ratio of 1:25.

Last Split Date Sep 7, 2022
Split Type Reverse
Split Ratio 1:25

Scores

INM has an Altman Z-Score of -10.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -10.91
Piotroski F-Score 3